BioNTech to construct vaccine manufacturing facility in Rwanda for distribution of vaccines to the wider continent

Covid vaccine access to lower- and middle-income nations has been a concern during the length of the pandemic, but BioNTech is now pushing forward for greater vaccine access for the African continent.

Construction work has kicked off for an mRNA manufacturing facility in Kigali, Rwanda. According to BioNTech, the facility, dubbed the African modular mRNA manufacturing facility, has a target for the first set of manufacturing tools to be delivered to the site by the end of this year.

Financial details on the project were not immediately available and questions from Endpoints News were not initially answered by BioNTech.

The company is expected to establish additional factories in Senegal and South Africa in close coordination with its partners in the respective countries. However, the initial site in Rwanda will become a node in a decentralized African end-to-end manufacturing network. All vaccines that will be manufactured in these nations will be…
Click here to view original post

Be the first to comment

Leave a Reply

Your email address will not be published.


*